Literature DB >> 26051417

Association of adiponectin gene polymorphism rs266729 with type two diabetes mellitus in Iraqi population. A pilot study.

Ahmed Naseer Kaftan1, Majid Kadhum Hussain2.   

Abstract

BACKGROUND: Diabetes incidence is increasing worldwide. Many studies demonstrated that polymorphisms within the adiponectin gene could be associated with type 2 diabetes mellitus (T2DM).
METHODS: A case-control study was conducted to find the association between SNP rs266729 and T2DM in Iraqi population. The study included 135 patients referring to diabetic clinic in Najaf city randomly selected based on World Health Organization (WHO) guidelines and 135 healthy controls. DNA was extracted from blood and genotyped by PCR-RFLP by using (HhaI) enzyme. Multinomial logistic regression was applied to compare the proportions of genotypes and alleles. The odds ratio for risk of developing T2DM was calculated with and without adjustment for age, sex, and BMI.
RESULTS: The frequency of the G allele of rs266729 (C/G) polymorphism was significantly higher (p=0.00) in diabetic subjects (28%) compared to that in normal subjects (14%). The homozygous genotype (GG) significantly (OR=3.67, CI 95%(1.25-10.76), P=0.01) increased the risk of T2DM by three folds with respect to those of the wild type (CC) after adjustment for age, sex and BMI, furthermore the heterozygous CG genotype significantly (OR=2.45, CI 95%(1.41-4.26), P=0.001) raised the risk of T2DM by two folds. Homozygous and heterozygous genotypes of rs266729 polymorphism exhibited significant association with raised fasting insulin values (p=0.01), and decreased HDL levels (p=0.00).
CONCLUSION: Adiponectin gene polymorphism rs266729 is involved in the pathogenesis of T2DM. In addition this SNP may play a role in the development of cardiovascular diseases and metabolic syndrome by affecting HDL and insulin levels.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adiponectin; Iraq; Polymorphism; rs266729

Mesh:

Substances:

Year:  2015        PMID: 26051417     DOI: 10.1016/j.gene.2015.06.004

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  The polymorphism of rs266729 in adiponectin gene and type 2 diabetes mellitus: A Meta-Analysis.

Authors:  Panpan Sun; Li Liu; Jiaxin Chen; Yuansi Chen; Litong Shi; Mustapha Umar Imam; Yanzi Chen; Xiaoting Pei; Yiping Xu; Yaxin Guo; Zhiguang Ping; Xiaoli Fu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

2.  Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ and cardiovascular disease: a meta-analysis.

Authors:  Joseph Sam Kanu; Shuang Qiu; Yi Cheng; Ri Li; Changgui Kou; Yulu Gu; Ye Bai; Jikang Shi; Yong Li; Yunkai Liu; Yaqin Yu; Yawen Liu
Journal:  Lipids Health Dis       Date:  2018-05-28       Impact factor: 3.876

3.  Association of ADIPOQ rs266729 and rs1501299 gene polymorphisms and circulating adiponectin level with the risk of type 2 diabetes in a population of Iran: a case-control study.

Authors:  Mahrokh Alimi; Mohammad Taghi Goodarzi; Mehdi Nekoei
Journal:  J Diabetes Metab Disord       Date:  2021-02-06

4.  High Molecular Weight Adiponectin Levels are Neither Influenced by Adiponectin Polymorphisms Nor Associated with Insulin Resistance in Mixed-ancestry Hyperglycemic Subjects from South Africa.

Authors:  Annalise E Zemlin; Tandi E Matsha; Andre P Kengne; Gloudina Hon; Rajiv T Erasmus
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

5.  Comparative effects of vitamin D and vitamin C supplementations with and without endurance physical activity on metabolic syndrome patients: a randomized controlled trial.

Authors:  Halgord Ali M Farag; Mohammad Javad Hosseinzadeh-Attar; Belal A Muhammad; Ahmad Esmaillzadeh; Abdel Hamid El Bilbeisi
Journal:  Diabetol Metab Syndr       Date:  2018-11-08       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.